PDA

View Full Version : Articles of Interest

Pages : 1 2 3 4 5 6 7 8 9 10 11 [12] 13 14 15
  1. Full length cytokeratin-19: a potential role in metastatic progression of bc
  2. Prognostic significance of FOXA1 and GATA-3 in breast cancer
  3. Controversial Cancer Stem Cells Offer New Direction For Treatment
  4. how the breast cancer suppressor gene P16 is silenced
  5. Vitamin-A Derivative Provides Clues To Better Breast Cancer Drugs
  6. Combination therapy for treating breast cancer using antiestrogen, ERA-923, and temsi
  7. The Depressing Thing About Cancer
  8. New Cancer Treatment Shows Promise in Testing
  9. Provectus now compassionate use (limited BC use)
  10. Apocrine sweat gland obstruction by antiperspirants and cancer
  11. Scientists Tackle Viral Mysteries
  12. Light Therapy Offers New Hope For Breast Cancer Patients
  13. New MRI Technique Could Mean Fewer Breast Biopsies In High-Risk Women
  14. PARP Inhibitors Represent New Direction in Cancer Treatment
  15. Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in bc
  16. The Effect of Modafinil on Cognitive Function in Breast Cancer Survivors
  17. "Fierce 15" for 2009 -Biotech companies with promising products
  18. Breast cancer treatments impact work status
  19. BC likelier for men from Camp Lejeune,NC
  20. Fewer Blood, Bladder, and Stomach Cancers in Vegetarians
  21. Sensors Act as a Chemical Nose to 'Sniff' for Abnormal Cells
  22. Stromal Marker For Breast Cancer Progression Identified
  23. The complexity of cell signalling pathways in oncology
  24. Blood pressure med may help bc.
  25. Less-Toxic Drug PProlongs Survival in Metastatic Breast Cancer
  26. The benefits of vitamin to prevent many cancers.
  27. Saint Barnabas Med. Ctr. is the only...
  28. Newly appreciated membrane ER
  29. Choice of Chemotherapy In Cancer Patients
  30. Wet Ear Wax, Osmidrosis May Be Linked With Breast Cancer Risk
  31. SNP linked to ER-positive, -negative breast cancer risk
  32. Adjuvant Radiotherapy Reduces Recurrences With Small Breast Tumors
  33. Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 & T Cell
  34. Src Helps Breast Cancer Cells To Survive In The Bone Marrow
  35. Predicting Endocrine Therapy Responsiveness in Breast Cancer (lots of info)
  36. One In Three Detected Breast Cancers Is Overdiagnosed
  37. Link Between Migraines And Reduced Breast Cancer Risk Confirmed
  38. Aromatase and bc in the elderly
  39. Most Oncologists Do Not Follow ASCO Guidelines on Fertility Preservation Counseling
  40. Glycemic load of diet tied to bc risk
  41. Relationship Between Age and Axillary Lymph Node Involvement in Women With BC
  42. Antimitotic chemos promote adhesion in detached and circulating tumor cells
  43. Alzheimer's Disease Drug Treats Traumatic Brain Injury
  44. Inhibiting LOX expression decreases tumor cell invasion & mets
  45. Breast Tumor Cells w/PI3K Mutation or HER2 + Selectively Addicted to Akt signaling
  46. Letrozole and tamoxifen differentially affect plasma hormones
  47. NEJM correspondence on trans and other fatty acids
  48. Fda odac opinion
  49. 'New era' in cancer research (Genomics)
  50. Insurers cut back cover for cancer as treatment costs soar
  51. Endocrine resistance...reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
  52. Inhibition of carbonic anhydrase IX: a new strategy against cancer.
  53. BRCA2 Breast Cancer More Sensitive to Chemotherapy
  54. No evidence for link between plasma micronutrient concentrations and postmeno bc
  55. Cancer and Sexuality
  56. Considering Longer Chemotherapy
  57. New way to kill cancer found using body's immune system
  58. Naltrexone: Sufferer joins in battle for trials of 'wonder drug'
  59. Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappa
  60. Risk of Breast Cancer After Radiotherapy in Childhood Quantified
  61. HER4 associates with increased sensitivity to Herceptin in MBC
  62. FDA Panel Votes Against Adding Doxil to Docetaxel for Advanced Breast Cancer
  63. Hypofractionated and Accelerated Radiotherapy With Subcutaneous Amifostine: Interim
  64. ASTRO Provides Guidance on Use of Partial-Breast Irradiation
  65. Imc-1121b
  66. CD1d-based combination therapy eradicates established tumors in mice.
  67. Sex steroid metabolism polymorphisms and mammographic density in pre- and peri-meno
  68. Patient's own stem cells used to cure cancer
  69. A novel role for STAT5b in beta1 integrin-mediated human breast cancer cell migration
  70. Breast Cancer Drug May Beat Fungal Infection
  71. Ovary Removal Linked to Increased Lung Cancer Risk
  72. Advances Elusive in the Drive to Cure Cancer
  73. Use of antioxidant supplements common during breast cancer treatment
  74. Research into application of thyroid cancer tx to bc
  75. Tumour aromatase expression as a prognostic factor for local control in young bc pts
  76. ridaforolimus may be able to overcome tumors that have become resistant to the cancer
  77. predicting pathologic response of breast cancer to three different chemotherapy regim
  78. Evolving Approaches to Metastatic Breast Cancer Previously Treated with Anthracycline
  79. Blood Pressure Drug (Losartan)Blocks Overexpression of Gene in Breast Cancer Patients
  80. Integration of complementary strategies for gene expression analysis to reveal novel
  81. A Potential Decision-Making Tool for Trastuzumab Use in Breast Cancer
  82. BC-associated metastasis is significantly increased in model of autoimmune arthritis
  83. Routine MRI use at time of dx to evaluate cancer
  84. 'Mindfulness' tips from ABTA
  85. Breast Cancer Patients Increasingly Opting for Mastectomy
  86. Migraine May Lower Breast-Cancer Risk
  87. Lack of Study Volunteers Hobbles Cancer Fight
  88. Inflammation-Associated Biomarkers Predict Breast Cancer Survival
  89. The way we eat....
  90. Cancer Genomes — Continuing Progress
  91. Outcome of Patients Treated With Doxorubicin As a Function of HER2 and TOP2A Status
  92. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effe
  93. Monotherapy Preferred for Metastatic Breast Cancer
  94. Pre-breast cancer surgery MRI
  95. The Fog That Follows Chemotherapy
  96. Doctor develops DNA vaccine to fight cancer
  97. Moderate Alcohol Consumption Increases Breast Cancer Risk
  98. Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel
  99. Skin telangiectasiae predicts radiation-induced CVD in breast cancer
  100. Breastfeeding Reduces Risk Of Breast Cancer In Women With A Family History Of BC
  101. Characterization of circulating tumor cells vs bone marrow disseminated cells in BC
  102. MicroRNA expression profiling of male breast cancer
  103. Drug Assistance Program
  104. Weight Lifting in Women with Breast-Cancer–Related Lymphedema
  105. Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
  106. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
  107. melts in your tumor, not in your blood
  108. Hi all!
  109. New Antibiotics (thiazole antibiotics) May Target Cancer-Causing Proteins
  110. How To Fine-Tune An Anti-Cancer Drug : Salinispora tropica
  111. Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
  112. Nanoparticulate Gene Therapy of Ovarian Cancer Aces Preclinical Trial
  113. Estrogen Therapy May Be Effective in Treating Breast Cancer Relapse
  114. Dietary and Stored Iron Are Associated With Breast Cancer
  115. Progesterone Leads To Inflammation, A Breast Cancer Risk Factor, Research Reveals
  116. Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
  117. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression
  118. Patterns and Risk Factors Associated With AI-Related Arthralgia Among BC Survivors
  119. Resident macrophages influence stem cell activity in the mammary gland
  120. Peritoneal Metastasis in Breast Cancer Signals Poor Prognosis
  121. Follow-Up After Grade 1 Breast Cancer May Not Be Needed
  122. International Comparison Reveals US Shortcomings in Clinical Trial Enrollment
  123. Estrogen Shrinks Tumors Refractory to Antiestrogen Therapy
  124. Rare Side Effect Is Seen in Long-Term Use of Tamoxifen
  125. A New Strategy for Immunotherapy of Cancer
  126. Study finds high patient exposure to radiation
  127. Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
  128. New Cancer Drug Delivery System Is Effective and Reversible: aptamers and the liposo
  129. Hot Flashes May Help Guide Breast Cancer Risk Reduction
  130. High dose Fulvestrant more effective than anastrozol for 1st line mets
  131. ? cure in bc populations followed for 23 years
  132. Surprising results of DCIS observation in mice
  133. New Data Confirm Lifestyle Changes Can Dramatically Reduce Risk for Breast Cancer
  134. Use of estradiol after development of resistance to AI
  135. Study mimics human DCIS in mouse models
  136. Breast Cancer: Discovery Leads To Rapid Mouse 'Personalized Trials'
  137. lapatinib before NAB Paclitaxel for advanced malignancies
  138. Delay to formalin fixation effect on breast biomarkers.
  139. Reversal effect and mechanism of lobeline on the multidrug-resistance of human breast
  140. Obesity, Alcohol Use And Smoking Increase The Risk Of Developing A Second Breast Canc
  141. Psychological Intervention Decreases Depression and Inflammation in Breast Cancer Pts
  142. Protein allows cells altered by the oncoprotein ErbB2/HER2 to escape their bonds
  143. Chlorophyllin selenium against cancer
  144. Intra-operative touch preparation cytology following lumpectomy for breast cancer
  145. Outcome of T1N0M0 bc in re: St. Gallen risk assignment criteria for adjuvant therapy
  146. Antioxidants and Cancer: Backwards?
  147. Great article on Vit D helping to prevent cancer...
  148. Little Information About Use And Accuracy Of Breast Cancer Tests
  149. Two New Publications at Breast Cancer Update site
  150. Several Breast Cancer Studies to Be Presented in Berlin May Change Practice
  151. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
  152. Showerheads may harbor bacteria dangerous to some
  153. Use of progestagens vs progesterone
  154. Occult Nipple Involvement in Breast Cancer
  155. Role of prognostic biomarkers (HR & HER2) in neoadjuvant therapy
  156. Irreversible Electroporation, or IRE: pulsed elctricity to treat cancers
  157. Prostate Cancer Drug Abiraterone Shows Impressive New Research Results (BC trial too)
  158. Pentoxifylline/Vitamin E Combo May Prevent Radiation induced Lymphadema
  159. Sentinel Node Findings Can Guide Axillary Treatment Choice
  160. Heating tumor (sarcoma) helps
  161. Perverse financial incentives tip usage in favor of IV drugs
  162. FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
  163. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells t
  164. Vaccine Boosts Trastuzumab in Treatment of HER2/Neu-Positive Breast Cancer (HER2/neu
  165. Amgen's motesanib (AMG-706), VEGF inhibitor in metastatic breast cance
  166. Pitt researcher gets $2.9M for lymph node study
  167. Prolonged clinical benefit from platinum-based chemotherapy in a patient with metasta
  168. Fatal pneumonitis after treatment with docetaxel and trastuzumab.
  169. Novel anti-tubulin cytotoxic agents for breast cancer.
  170. Aldose Reductase: A Novel Therapeutic Target for Inflammatory Pathologies
  171. Einstein Researchers Identify Potential Target for Metastatic Cancer
  172. Integrin alpha2 mediates selective metastasis to the liver.
  173. Nanoparticle 'Nanobees' Deliver Bee Venom Agent to Tumors
  174. Monitoring by CTCs for metastatic bc, related to radiographic testing
  175. Stereotactic body radiation (SBRT) therapy for liver metastas
  176. Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the gro
  177. Cancer and immunization (thread)
  178. Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic
  179. Underweight and Breast Cancer Recurrence and Death
  180. Editorial from the Journal of Clinical Oncology: How to treat triple postive BC
  181. Berberine-natural product against cancer and more
  182. Melatonin inhibits aromatase promoter expression
  183. Adjuvant! OnLine overestimates survival in British study
  184. Interesting Review of Tamoxifen vs. AI study results
  185. Accuracy of Conflict-of-Interest Disclosures Reported by Physicians
  186. CYP2D6 Influence on Tamoxifen Response
  187. Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity a
  188. Lapatinib: A competitor or companion to trastuzumab?
  189. Vitamin D good for breast cancer patients
  190. Tiny chip can measure estrogen in breast tissue
  191. Tykerb® plus Femara® Improves Quality-adjusted Survival in Women with HER2+ Metastati
  192. Targeting the Triple Threat -Triple Negative Breast Cancer
  193. Distinct inherited metastasis susceptibility exists for different bc subtypes
  194. Underuse of BC Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical Mistrust
  195. Sonographic and Electrodiagnostic Evaluations in Patients With AI-Related Arthralgia
  196. Comparative Analysis of Bone Marrow Micrometastases W/SLNode Status in Early Stage BC
  197. Dasatinib (synergizes with chemo)
  198. ANG1005-Taxol derivative crosses BBB
  199. Müllerian inhibiting substance linked to increased breast cancer risk
  200. In Shift, Cancer Society Has Concerns on Screenings
  201. Lost in Transmission — FDA Drug Information That Never Reaches Clinicians
  202. Breast cancer sufferers will be denied life-extending drug (NHS: Lapatainib)
  203. MicroRNA replacement provides an effective therapy in cancer
  204. Cardiovascular Risk Greater Than Breast Cancer Recurrence Risk in Some Patients
  205. Analgesics Underused by Breast Cancer Patients
  206. Combination of bisphosphonates and antiangiogenic=more Osteteonecrosis of the jaw
  207. Comparable Results From Three Forms of Accelerated Partial-Breast Irradiation
  208. Genotyping Plus Family History May Change Breast Cancer Risk Estimates
  209. CHEK2 Mutation Increases Mortality, Breast Cancer Recurrences
  210. HER1-4 protein concentrations in normal tissue..same profile as malignant
  211. CirculatingTumor Cell and serum Her2, downloadable
  212. Noscapine: Anti-cancer couph syrup (no joke)
  213. Off-label Cancer Treatments and cocktail (website)
  214. Cancers Can Vanish Without Treatment, but How?
  215. Circadian Rhythm, eating schedule etc and treatment
  216. Update on the use of AI's in early stage BC
  217. Where to Go for Cancer Care—A Shot in the Dark
  218. Discovery of a selective Cyclin D Kinase Inhibitor that inhibts +++ bc in vitro
  219. NCCN Guidelines Discourages Prophylactic Mastectomy In Women Other Than For High Risk
  220. Gastroenterologists Explore Relationship Between Bacteria In The Gut And BC
  221. Nulliparity, Late Age at First Childbirth Linked to Aggressive Breast Cancer
  222. Cancer and Diarrhea: Rising Incidence of an Old Problem
  223. 3-bromopyruvate
  224. anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccinatio
  225. Gossypol: cotton derivative synergizes with chemo
  226. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cel
  227. Kanzius "machine" -heated nanoparticles
  228. The HER2 and HER3 Interaction
  229. Aspirin and cancer: Patience in research
  230. Radiological staging in breast cancer: which asymptomatic patients to image and how
  231. Change in the hormone receptor status following administration of neoadjuvant chemo
  232. circulating tumor cells as a surrogate for response to treatment
  233. Tamoxifen (ER+, ER-, synergies etc)
  234. Genspera's G202: 12ADT toxin unwrapped by enzymes, "effective monotherapy"
  235. In Atypical Ductal Hyperplasia, Absence of Cytokeratin 5 Expression Is Ominous
  236. Breast cancer changes with spread
  237. T-DMI (trastuzumab plus DMI)
  238. Small, node-negative her2-positive BC much more likely than her2-negative to spread
  239. Mutational Evolution in a Lobular Breast Cancer Demonstrates Value of DNA sequencing
  240. Fluoxetine i.e. Prozac: anticancer agent
  241. Rexin-G
  242. Review: New diagnostics and biological predictors of outcomes
  243. Aspirin as anticancer agent
  244. New Method Targets Cancerous Tumors Without Harming Healthy Cells
  245. Scanning and imaging developments
  246. Sorafenib (Nexavar)
  247. Hes-6, potential oncogene in bc, is regulated by ER and promotes proliferation
  248. Repeat FISH Testing of Breast Tissue Not Cost-Effective for Her-2/neu Determination
  249. Neratinib
  250. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K